274 related articles for article (PubMed ID: 23009903)
1. A polymorphism in the leptin receptor gene at position 223 is associated with growth hormone replacement therapy responsiveness in idiopathic short stature and growth hormone deficiency patients.
Su PH; Yang SF; Yu JS; Chen SJ; Chen JY
Eur J Med Genet; 2012 Dec; 55(12):682-7. PubMed ID: 23009903
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphisms in leptin and its receptor and the response to growth hormone treatment in patients with idiopathic growth hormone deficiency.
Hwang IT; Kim M; Kim NY; Yoon JS; Lee HJ; Jeong HR; Shim YS; Kang MJ
Endocr J; 2021 Aug; 68(8):889-895. PubMed ID: 33762520
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
[TBL] [Abstract][Full Text] [Related]
4. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
[TBL] [Abstract][Full Text] [Related]
5. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
Colmenares A; González L; Gunczler P; Lanes R
J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
[TBL] [Abstract][Full Text] [Related]
6. Leptin expression and leptin receptor gene polymorphisms in growth hormone deficiency patients.
Su PH; Chen JY; Yu JS; Chen SJ; Yang SF
Hum Genet; 2011 Apr; 129(4):455-62. PubMed ID: 21207066
[TBL] [Abstract][Full Text] [Related]
7. LEPR p.Q223R Polymorphism influences plasma leptin levels and body mass index in Tunisian obese patients.
Ben Ali S; Kallel A; Sediri Y; Ftouhi B; Feki M; Slimene H; Jemaa R; Kaabachi N
Arch Med Res; 2009 Apr; 40(3):186-90. PubMed ID: 19427969
[TBL] [Abstract][Full Text] [Related]
8. Are genes associated with energy metabolism important in asthma and BMI?
Szczepankiewicz A; Breborowicz A; Sobkowiak P; Popiel A
J Asthma; 2009 Feb; 46(1):53-8. PubMed ID: 19191138
[TBL] [Abstract][Full Text] [Related]
9. Study of leptin levels and gene polymorphisms in patients with central precocious puberty.
Su PH; Yang SF; Yu JS; Chen SJ; Chen JY
Pediatr Res; 2012 Apr; 71(4 Pt 1):361-7. PubMed ID: 22391636
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
11. Study of the leptin levels and its gene polymorphisms in patients with idiopathic short stature and growth hormone deficiency.
Su PH; Yang SF; Yu JS; Chen SJ; Chen JY
Endocrine; 2012 Aug; 42(1):196-204. PubMed ID: 22350661
[TBL] [Abstract][Full Text] [Related]
12. The effect of growth hormone treatment on height in children with idiopathic short stature.
Jeong HR; Shim YS; Lee HS; Hwang JS
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
[TBL] [Abstract][Full Text] [Related]
15. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
Reinehr T; Bechtold-Dalla Pozza S; Bettendorf M; Doerr HG; Gohlke B; Hauffa BP; Kaspers S; Land C; Mehls O; Schwab KO; Stahnke N; Ranke MB;
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):544-8. PubMed ID: 22006181
[TBL] [Abstract][Full Text] [Related]
16. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
17. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
Brandl EJ; Frydrychowicz C; Tiwari AK; Lett TA; Kitzrow W; Büttner S; Ehrlich S; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ; Puls I
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):134-41. PubMed ID: 22426215
[TBL] [Abstract][Full Text] [Related]
18. The effect of ponderal index at birth on the relationships between common LEP and LEPR polymorphisms and adiposity in adolescents.
Labayen I; Ruiz JR; Moreno LA; Ortega FB; Beghin L; DeHenauw S; Benito PJ; Diaz LE; Ferrari M; Moschonis G; Kafatos A; Molnar D; Widhalm K; Dallongeville J; Meirhaeghe A; Gottrand F;
Obesity (Silver Spring); 2011 Oct; 19(10):2038-45. PubMed ID: 21512510
[TBL] [Abstract][Full Text] [Related]
19. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
[TBL] [Abstract][Full Text] [Related]
20. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
